SUBSCRIBE
Biohealth Innovation
Founding Member of
SUBSCRIBE
Events Calendar
9th Annual BioHealth Capital Region Forum
Join us for the 9th Annual BioHealth Capital Region Forum on September 19th and 20th, 2023, at US Pharmacopeia (USP) located at 12601 Twinbrook Pkwy, Rockville, MD 20850. This year, we are excited to announce that the Forum will be an entirely in-person event, responding to the feedback of our stakeholders.
The BioHealth Capital Region Forum serves as the premier gathering for the biopharma sector, bringing together over 1,100 registrants annually, including esteemed government officials, academic leaders, and industry executives. This event offers a unique opportunity to reconnect, rekindle partnerships, and explore new avenues for growth within the region.
As the flagship event of the BioHealth Capital Region, the Forum showcases the region's strengths, celebrates successes, and delves into future trends. It provides a platform for thought-provoking discussions, knowledge sharing, and fostering collaborations that advance both public health and economic outcomes. With over 2,300 life science companies, 78 federal labs, and a host of renowned academic institutions, the BioHealth Capital Region is a thriving hub of innovation and opportunity.
Furthermore, we are thrilled to announce that following the Forum, the 6th Annual BioHealth Capital Region Investment Conference will take place on September 21st at the same location. This conference offers an exclusive platform for investment and partnership opportunities within the vibrant biohealth industry.
Mark your calendars and be a part of these prestigious events as we gather to shape the future of the BioHealth Capital Region and drive breakthroughs in the life sciences field. Stay tuned for further updates and registration details. We look forward to welcoming you to this gathering of industry leaders and visionaries.
8th Annual BioHealth Capital Region Crab Trap
- A $10,000 cash prize from Greenberg Traurig
- A $25,000 cash prize from Montgomery County (for a firm headquartered in Montgomery County)
- A one-year residency at JLABS @ Washington, D.C. (for a firm of their choice)
- $10,000 in Preclinical CRO services from Noble Life Sciences.
6th Annual BioHealth Capital Region Investment Conference
Join us for the 6th Annual BioHealth Capital Region Investor Conference, taking place on September 21st, 2023, at the US Pharmacopeia. This highly anticipated in-person event brings together ambitious entrepreneurs and BioHealth companies with a diverse group of influential investors, offering funding opportunities ranging from pre-seed to Series A.
Set in the heart of the thriving BioHealth Capital Region, this conference has a remarkable track record of cultivating success stories, leading to initial and follow-up financings, IPOs, and M&A activities. The conference maintains rigorous standards through a meticulous three-step selection process. First, companies submit detailed applications outlining their operations and financing needs. Next, selected companies create compelling online profiles for investor review. Finally, investors schedule exclusive meetings with the companies that capture their interest during the conference.
This event represents an unparalleled opportunity for companies seeking investment to engage with key investors actively seeking promising ventures. If you are an entrepreneur or a BioHealth company looking to take your business to the next level, register now to secure your spot and unlock the potential for transformative funding. Click here to register your company to meet with investors.
Investors, if you are seeking to invest in cutting-edge BioHealth ventures and discover the next breakthrough innovation, don't miss out on this exclusive gathering of visionary entrepreneurs. Register your interest today to connect with high-potential companies and be part of the dynamic BioHealth ecosystem. Click here to register as an investor looking to invest in companies.
EIR Feedback Day - September 27
This free 1:1 virtual session is an opportunity to discuss your company with experts in diagnostics, therapeutics, digital health and medical devices.
If you’re a growth-stage biohealth company looking for unbiased advice on your pitch deck, commercialization strategy, evidence development or entrepreneurial challenges, our EIRs can help.
To request a feedback session, please send a non-confidential pitch deck, and a short description of the input you’re seeking from the EIRs, to Dr. Monique Bennett: mbennett@
The requested information should be received by our office at least 2 weeks in advance, so that we can schedule the appropriate experts. Thank you!
Pitch Perfected: Best Practices in Pitching & Presenting for Life Science Startups
A chance to pitch to an investor or potential partner is a golden opportunity for a biotech startup. It’s also a pressure-packed moment where every minute counts. No matter how great your product or company may be or how valuable your solution may prove to be for patients, you and your team need to convey that impact and tell your story in a way that connects with your audience.
It is vital to make the most of the opportunity, going into each pitch with a plan and applying communications best practices, to ensure you deliver the message that you intend and set the stage for further discussions.
Join Jennifer Cosenza from the Catalytic Agency, a firm specializing in branding and messaging for emerging life science companies, for this session that will walk attendees through best practices for delivering the right message to the right audience to meet your desired goals. From developing a pitch plan, perfecting your story, and crafting a meaningful call to action, to building a presentation that supports all of these elements, you’ll leave this session with the knowledge and tools to enhance and elevate your pitch.
https://bit.ly/47TG9ty
Women Building Bio 2023
Virginia Bio’s Women Building Bio Conference celebrates the contribution of women to the life sciences in the Commonwealth and beyond. The 8th annual conference theme, Building Better, will prompt us to explore how life sciences contribute to building a better future and highlight the increasingly significant role of women in it.
September 28, 2023
8:30 am – 4:00 pm
Hylton Performing Arts Center
Manassas, Virginia
If you are interested in event sponsorship, please contact Frank Wilton.
https://events.bizzabo.com/494489
EIR Feedback Day - October 18
This free 1:1 virtual session is an opportunity to discuss your company with experts in diagnostics, therapeutics, digital health and medical devices.
If you’re a growth-stage biohealth company looking for unbiased advice on your pitch deck, commercialization strategy, evidence development or entrepreneurial challenges, our EIRs can help.
To request a feedback session, please send a non-confidential pitch deck, and a short description of the input you’re seeking from the EIRs, to Dr. Monique Bennett: mbennett@
The requested information should be received by our office at least 2 weeks in advance, so that we can schedule the appropriate experts. Thank you!
BioBuzz’s Oktoberfest
https://biobuzz.io/event/biobuzzs-oktoberfest/
Need a job in the “wurst” way? Join BioBuzz, CRB, and top employers in the region for one of our most anticipated events of the year: Oktoberfest.
Having trouble RSVPing using the button above? Sign up directly via Eventbrite HERE.
ABOUT CRB
CRB is a leading international provider of sustainable engineering, architecture, construction, and consulting solutions to the life sciences industry.
BioBuzz has been hosting biotech and life science community events since 2009 and has fostered a vibrant community of industry professionals and leaders across the Mid-Atlantic region. Be sure to dig in with our news coverage of the BioHealth Capital Region(and beyond), peruse our Job Board or check out all of our available Employer Resources.
NCI Technology Opportunities Webinar: Anti-EGFR Antibodies for the Treatment of Human Cancers
Register to attend a free NIH webinar. Attendees will learn about new antibodies developed in Dr. David Fitzgerald’s Lab that bind a particular structure on the external domain of epidermal growth factor receptor (EGFR) which is displayed on cancer cells that express high EGFR levels or the variant termed ‘EGFRvIII’. Importantly, these antibodies do not bind normal cells. Therefore, these antibodies are used to deliver toxic payloads (as antibody-drug conjugates - ADCs) to cancer cells without killing normal cells. Additionally, these antibodies are superior to currently approved drugs that target this receptor, including ligand-blocking monoclonal antibodies and small molecular weight kinase inhibitors. Further, this presentation will show that tumors expressing high levels of human EGFR experience a significant reduction in size after treatment with several distinct ADCs made in Dr. Fitzgerald’s Lab.
Webinar overview: The presentation will follow a logical sequence of how anti-EGFR antibodies are generated and modified to make them cytotoxic for tumor cells with high levels of EGFR or the variant EGFRvIII; specifically focusing on beginning with a key mouse monoclonal antibody termed ‘40H3’ and then transitioning to the humanization of this antibody to produce the antibody termed ‘A10’. These anti-EGFR antibodies can be used as either independent agents or targeting domains in recombinant immunotoxins (RITs), antibody-drug conjugates (ADCs), bispecific antibodies, and chimeric antigen receptors (CARs).
Indo US Bridging RARE Summit 2023
Scheduled for October 29-30, 2023, at the George Mason University Campus in Arlington, VA, the Indo US Bridging RARE Summit 2023 aims to unite the global rare disease community and raise awareness about these conditions. While rare diseases are increasingly understood in the United States and Europe, there remains a lack of awareness in other parts of the world, including India. By addressing this gap, the summit aims to make a positive impact on the lives of 1.5 billion people in India and the global population of 8 billion.
Bringing together leaders representing diverse stakeholders in rare diseases, the summit serves as a platform for knowledge-sharing, exchanging experiences, and fostering collaborations to address the challenges faced by rare disease patients and their families. The event covers crucial themes such as cross-border patient engagement, care pathways encompassing screening, diagnosis, and treatment options, digitization of rare diseases including registries and emerging markets, diversity, equity, and inclusion in the globalization of orphan drugs, orphan drug clinical trials, and regulatory pathways.
IndoUSrare, the organizing body behind the summit, is committed to connecting rare disease patients worldwide and prioritizing education, research, and engagement to enhance their quality of life.
For sponsorship opportunities and event information, interested individuals can contact summit@indousrare.or and visit https://www.indousrare.org/summit/. The Indo US Bridging RARE Summit 2023 is an important platform for collaboration and knowledge exchange to make a positive impact on the rare disease community worldwide.
The summit planning committee includes prominent individuals representing various organizations and institutions involved in rare disease research and advocacy. Some of the committee members are:
- Amy Adams, Ph.D. - Institute for Biohealth Innovation, George Mason University
- Rich Bendis - BioHealth Innovation and BioHealth Capital Region Forum
- Anish Bhatnagar, MD - IndoUSrare and Soleno Therapeutics
- Madhulika Kabra, MD - All India Institute of Medical Sciences (AIIMS, Delhi)
- Reena Kartha, MS, Ph.D. - IndoUSrare and Center for Orphan Drug Research, UMN
- Juhi Naithani, MBA - IndoUSrare and bGlobal Consulting
- John Newby, JD - Virginia Bio
- Harsha Rajasimha, MS, Ph.D. - IndoUSrare and Jeeva Informatics Solutions
- Frank Sasinowski, MPH, JD - IndoUSrare and Hyman Phelps McNamara PC
- Bhaskar Sonowal, MBBS, MBA - IndoUSrare and HED Healthcare
- K Thangaraj, Ph.D. - Centre for DNA Fingerprinting and Diagnostics (CDFD)?